Given the demonstrated inhibitory effect of APOE on AR transcriptional activity, which contributes to the intrinsic resistance of APOE-high PCa to AR-targeted therapies, we proceeded to assess the responsiveness to ADT in APOE-high PCa. The gene discussed is AR; the disease is posterior cortical atrophy.